Short wave diathermy is it really good deep heating electromagnetic therapy it's side effects why it's is banned in some country with evidance and what are 2 it's alternative modalities that provides more deep or same effects in Physiotherapy
Short wave diathermy is it really good deep heating electromagnetic therapy it's side effects why it's is banned in some country with evidance and what are 2 it's alternative modalities that provides more deep or same effects in Physiotherapy
short wave diathermy deep heating electromagnetic therapy physiotherapy efficacy
Diagnosis And Treatment Of Low Back Pain
Page 106
short wave diathermy side effects contraindications adverse effects banned countries
Diagnosis And Treatment Of Low Back Pain
Page 106
| Mode | Mechanism | Primary Target Tissue |
|---|---|---|
| Continuous SWD (CSWD) | Thermal — oscillating electromagnetic field causes ionic agitation and molecular friction | Deep muscles, joints (up to 3–5 cm depth) |
| Pulsed SWD (PSWD) | Non-thermal/athermal — brief energy bursts with rest periods; biostimulation effects | Superficial + deep tissues; edema, nerve repair |
| Side Effect | Cause |
|---|---|
| Burns (thermal) | Excessive intensity, wet skin/towels, metal implants concentrating field, patient insensitivity to heat |
| Skin erythema and blistering | Localized overheating, especially over bony prominences |
| Deep tissue burns | Metal objects (IUDs, surgical clips, jewelry) act as antennas and concentrate current |
| Electric shock / arc burns | Equipment faults, frayed leads |
| Headache/dizziness | Application near the head; induced currents in CNS |
| Fetal harm | Strong contraindication in pregnancy — embryotoxic and teratogenic effects documented in animal studies |
| Cardiac arrhythmia | Electromagnetic interference with pacemakers — potentially fatal |
| Concern | Evidence |
|---|---|
| Carcinogenicity | WHO IARC: SWD occupational exposure classified as possible carcinogen (Group 2B). Studies show increased risk of specific cancers (breast, leukemia) in physiotherapists with chronic unprotected exposure |
| Reproductive hazards | Lerman et al. (1999) and Taskinen et al. (1990) found increased rates of spontaneous abortion in female physiotherapists using SWD during pregnancy |
| Ocular damage | Prolonged exposure linked to cataracts (lens of eye is avascular and cannot dissipate heat) |
| Testicular damage | Scrotal/gonadal heating — azoospermia risk in male patients receiving pelvic SWD |
| Electromagnetic interference | Disrupts electronic implants (cochlear implants, neurostimulators, insulin pumps) |
| Parameter | Details |
|---|---|
| Frequency | 1 MHz (deep: 3–5 cm) or 3 MHz (superficial: 1–2 cm) |
| Mechanism | Acoustic energy → mechanical vibration of molecules → thermal + non-thermal (cavitation, acoustic streaming) effects |
| Heating depth | 3–5 cm at 1 MHz — comparable to or exceeding inductive SWD |
| Precision | Focused beam → more targeted than SWD; no electromagnetic leakage to therapist |
| Modes | Continuous (thermal), Pulsed (non-thermal/biostimulation) |
| Parameter | Details |
|---|---|
| Frequency | 2,450 MHz (wavelength 12.25 cm) |
| Mechanism | Microwave radiation → rotation of polar molecules (especially water) → deep tissue heating |
| Heating depth | 3–5 cm — effectively heats muscle tissue (water-rich) more selectively than SWD |
| Selectivity | Preferentially heats muscle over fat (unlike capacitive SWD) — more therapeutically efficient |
| Application | Non-contact direct beam applicator |
| Feature | SWD | Therapeutic Ultrasound | Microwave Diathermy |
|---|---|---|---|
| Depth of heating | 3–5 cm (inductive) | 3–5 cm (1 MHz) | 3–5 cm |
| Tissue selectivity | Poor (heats fat heavily) | Excellent (focused beam) | Good (heats muscle > fat) |
| Non-thermal effects | Yes (pulsed mode) | Yes (pulsed mode — strong) | Minimal |
| Operator EMF risk | High (IARC 2B) | None | Low |
| Metal implants | Absolute contraindication | Relative caution | Contraindicated |
| Pregnancy risk | High | Caution (avoid abdomen) | Moderate |
| Evidence base | Moderate, inconsistent | Strong | Moderate |
| Regulatory status | Restricted/banned in EU, UK, AUS, CAN | Widely approved | Approved, limited use |
| Cost/availability | Decreasing | High availability | Moderate |
Knee buckling after TKR and not able to sleep in night after knee or any other surgery reason
knee buckling giving way after total knee replacement causes management
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 10413
sleep disturbance insomnia after surgery post operative pain management
Management of Glenohumeral Joint Osteoarthritis
Page 47
quadriceps weakness instability complications after TKR total knee arthroplasty rehabilitation
postoperative sleep disruption causes pain inflammation cortisol opioids circadian rhythm
| Quadriceps Strength Required | Clinical Activity |
|---|---|
| >60% of contralateral limb | Level walking |
| >70–80% | Stair climbing |
| >85% | Rising from chair without arms |
| Sign | Suspect |
|---|---|
| Fever, warmth, elevated ESR/CRP | Periprosthetic infection |
| Sudden onset after trauma | Component fracture or dislocation |
| Progressive worsening >1 year post-op | Aseptic loosening, polyethylene wear |
| Foot drop + buckling | Peroneal nerve injury |
| Varus/valgus thrust on gait | Ligamentous instability |
| Intervention | Rationale |
|---|---|
| Quadriceps strengthening (SLR, VMO activation, terminal knee extension) | Restores primary dynamic stabilizer |
| Neuromuscular electrical stimulation (NMES/EMS) | Overcomes AMI — directly activates inhibited quadriceps |
| Balance and proprioception training (single-leg stance, wobble board) | Compensates for lost mechanoreceptors |
| Gait re-education | Corrects antalgic and Trendelenburg patterns |
| Knee brace (hinged orthosis) | External stabilization during rehabilitation |
| EMG biofeedback | Improves VMO recruitment awareness |
| Cause | Mechanism |
|---|---|
| Surgical tissue damage | Nociceptive pain from incision, bone cutting, retraction → constant or movement-related pain at night |
| Inflammatory mediators | IL-1β, TNF-α, PGE2 released post-surgically → lower pain threshold and disrupt sleep architecture directly |
| Positional pain | Inability to find a comfortable sleep position (especially after knee, hip, shoulder surgery) |
| Rebound pain | Pain analgesics (especially short-acting opioids) wearing off at night → abrupt pain spike at 2–4 AM |
| Neuropathic pain | Nerve damage/traction during surgery → burning, electric, or throbbing pain worse at night (neuropathic pain follows a nocturnal pattern) |
| Drug | Sleep Effect |
|---|---|
| Opioids (morphine, oxycodone, tramadol) | Suppress REM sleep and slow-wave (deep) sleep → non-restorative sleep, vivid dreams, frequent arousals |
| Steroids (dexamethasone) | Given perioperatively → stimulant effect → insomnia, especially if dosed in the evening |
| NSAIDs | Generally sleep-neutral, but GI discomfort can disrupt sleep |
| Antibiotics (fluoroquinolones) | CNS stimulation → insomnia |
| Anesthetic agents | Residual effects of general/spinal/epidural anesthesia disrupt normal sleep architecture for days to weeks |
| Cause | Mechanism |
|---|---|
| Disrupted circadian rhythm | Surgical stress elevates cortisol and catecholamines → delays melatonin secretion → phase-shifts the sleep-wake cycle |
| Suppressed melatonin | Operating room lighting, ICU/ward lighting, preoperative fasting, and anesthesia all suppress melatonin production |
| Altered sleep architecture | Anesthesia blocks normal REM cycling. Post-op = "REM rebound" nights (vivid, disturbing dreams) and loss of slow-wave sleep |
| Central sensitization | Prolonged pain → spinal and supraspinal sensitization → hyperalgesia and allodynia that worsens at night when distracting stimuli are absent |
| Cause | Description |
|---|---|
| Anxiety | Fear of falling, implant failure, returning to work; hyperarousal state prevents sleep onset |
| Post-operative depression | Common after major surgery; depressed mood ↔ insomnia in a bidirectional cycle |
| Post-ICU syndrome | After major surgeries requiring ICU stay — PTSD-like symptoms, fragmented sleep |
| Catastrophizing | Pain catastrophizing (rumination, magnification) strongly predicts post-op insomnia |
| Cause | Mechanism |
|---|---|
| Post-operative fever | Pyrogenic cytokines (IL-1, IL-6) disrupt normal sleep stages; sweating causes discomfort |
| Urinary retention | Common after spinal/epidural anesthesia or with opioids → nocturia, bladder discomfort |
| Deep vein thrombosis (DVT) | Leg pain and swelling — nocturnal worsening is characteristic of DVT post-TKR |
| Immobility | Prolonged bed rest reduces adenosine (sleep pressure) buildup → less sleep drive at night |
| Swelling and edema | Post-TKR limb swelling peaks at 48–72 hours → throbbing, pressure sensation → arousals |
| Restless leg syndrome (RLS) | Opioid use and iron deficiency (post-surgical blood loss) can trigger or worsen RLS |
| Sleep apnea worsening | Opioids suppress respiratory drive → worsening of pre-existing or new obstructive sleep apnea post-op |
| Cause | Description |
|---|---|
| Noise (alarms, ward activity) | Prevents deep sleep stages |
| Light exposure | Suppresses melatonin |
| Nursing interruptions | Vitals, dressings, IV medications every 2–4 hours |
| Unfamiliar environment | "First-night effect" in new sleep environments |
| Uncomfortable bed/positioning | Inability to self-reposition due to surgical limb |
| Intervention | Description |
|---|---|
| Limb elevation | Reduces post-TKR edema and nocturnal throbbing |
| Ice/cryotherapy before bed | Reduces swelling and pain, promotes vasoconstriction |
| Sleep hygiene education | Consistent sleep/wake times, dark quiet room, no screens |
| Positioning aids | Pillow under/between knees for hip and knee surgery patients |
| Relaxation techniques | Progressive muscle relaxation, breathing exercises, guided imagery |
| Graded activity during day | Increases adenosine sleep pressure; reduces daytime napping |
| Cognitive Behavioral Therapy for Insomnia (CBT-I) | Gold standard for chronic post-surgical insomnia |
| Drug | Role |
|---|---|
| Melatonin 2–5 mg | Restores circadian rhythm, safe, no dependency |
| Pregabalin/gabapentin | For neuropathic component; also reduces anxiety; improves sleep quality |
| Low-dose amitriptyline | For combined neuropathic pain + insomnia |
| Multimodal analgesia optimization | Long-acting analgesics timed for nighttime coverage (avoid opioid gaps at 2–4 AM) |
| Short-term low-dose benzodiazepines or Z-drugs | Only if severe; short course; watch for apnea risk |
KNEE BUCKLING AFTER TKR
├── Quadriceps weakness / AMI (most common)
├── Ligamentous instability (MCL/LCL/PCL)
├── Component issues (loosening, malalignment, wear)
├── Patellofemoral dysfunction
├── Proprioception loss
├── Peroneal nerve injury
└── Infection (PJI) ← must exclude
POST-SURGICAL INSOMNIA
├── Pain (nociceptive + neuropathic)
├── Opioid/steroid/anesthetic drug effects
├── Circadian disruption (↓ melatonin, ↑ cortisol)
├── Anxiety, depression, catastrophizing
├── Systemic: fever, DVT, edema, RLS, apnea
└── Environmental (hospital noise, light, interruptions)